Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Cannabinoid Receptor Type 1 (CB1) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid Receptor Type 1 (CB1) Antagonists....
Jan 2016 $ 1250
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Cannabinoid Receptor Type 2 (CB2) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid Receptor Type 2 (CB2) Agonists. The D...
Jan 2016 $ 1250
Carbonic Anhydrase 1 (CA1) Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Carbonic Anhydrase 1 (CA1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Carbonic Anhydrase 1 (CA1) Inhibitors. The DelveInsigh...
Jan 2016 $ 1250
Carbonic Anhydrase 2 (CA2) Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Carbonic Anhydrase 2 (CA2) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Carbonic Anhydrase 2 (CA2) Inhibitors. The DelveInsigh...
Jan 2016 $ 1250
Carbonic Anhydrase Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Carbonic Anhydrase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Carbonic Anhydrase Inhibitors. The DelveInsight's Report cover...
Jan 2016 $ 1250
Carnitine Palmitoyltransferase I (CPT 1) Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Carnitine Palmitoyltransferase I (CPT 1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Carnitine Palmitoyltransferase I (CPT 1)...
Jan 2016 $ 1250
CCR1 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CCR1 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CCR1 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CCR2 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CCR2 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CCR2 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CCR3 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CCR3 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CCR3 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CCR4 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CCR4 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CCR4 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CCR5 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CCR5 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CCR5 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CCR9 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CCR9 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CCR9 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CD (Cluster of Differentiation) Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD (Cluster of Differentiation) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD (Cluster of Differentiation) Inhibitors. The D...
Jan 2016 $ 1250
CD 19 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD 19 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 19 Inhibitors. The DelveInsight's Report covers the product profiles in ...
Jan 2016 $ 1250
CD 3 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD 3 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 3 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CD 30 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD 30 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 30 Inhibitors. The DelveInsight's Report covers the product profiles in ...
Jan 2016 $ 1250
CD 33 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD 33 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 33 Inhibitors. The DelveInsight's Report covers the product profiles in ...
Jan 2016 $ 1250
CD 4 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD 4 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 4 Inhibitors. The DelveInsight's Report covers the product profiles in va...
Jan 2016 $ 1250
CD 40 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD 40 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 40 Inhibitors. The DelveInsight's Report covers the product profiles in ...
Jan 2016 $ 1250
CD152 Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD152 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD152 Inhibitors. The DelveInsight's Report covers the product profiles in ...
Jan 2016 $ 1250
CD4+ T cell Activators -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD4+ T cell Activators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD4+ T cell Activators. The DelveInsight's Report covers the product ...
Jan 2016 $ 1250
CD40 Agonists -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD40 Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD40 Agonists. The DelveInsight's Report covers the product profiles in variou...
Jan 2016 $ 1250
CD8+ T cell Activators -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "CD8+ T cell Activators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD8+ T cell Activators. The DelveInsight's Report covers the product ...
Jan 2016 $ 1250
Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cell Division Cycle 7 (CDC7) ...
Jan 2016 $ 1250
Cell Wall Synthesis Inhibitors -Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, "Cell Wall Synthesis Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cell Wall Synthesis Inhibitors. The DelveInsight's Report cov...
Jan 2016 $ 1250